Green Valley is an innovative-driven biopharmaceutical company. Our core competitiveness lies in the ability to explore the pathogenesis of diseases.
Green Valley’s scientific research and innovation is based on originality, which lies at the heart and soul of our company. We are committed to providing innovative medicines and health programs that people yearn for for long.
the world's first multi-targeting oligosaccharide for treatment of patients with mild-to-moderate Alzheimer's disease
Here provides press releases and news of Green Valley.
We are aspired to attract outstanding talents with shared values to accomplish great achievement together with the company.
Therapeutic Area: Cardiovascular disease